Oncology
Jul 25, 2008
Imclone CEO: KRAS Testing Is Long-Term Positive For Erbitux
"We do not believe that this will negatively impact our long-term prospects in colorectal cancer," said Johnson during the New York biotech company's conference call Thursday.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Genetic tests may pinpoint who should get Avastin | Sun | Gail Perry | 8 |
| Program Offers Lifeline To Those Lost In The Tr... | Sat | Gail Perry | 3 |
| Second lumpectomy for breast cancer reduces sur... | Oct 4 | Gail Perry | 1 |
| Breast cancer survivor delivers 'miracle baby' | Oct 3 | Todd Cubitt | 11 |
| Hypnosis eases post-breast cancer hot flashes | Oct 3 | Gail Perry | 1 |
| Feeding your body's defenses against cancer | Oct 2 | Gail Perry | 2 |
| DeLauro's triumph | Oct 2 | Tax and Spend | 1 |
Libra
Most Popular